全文获取类型
收费全文 | 4426篇 |
免费 | 267篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 92篇 |
儿科学 | 94篇 |
妇产科学 | 60篇 |
基础医学 | 531篇 |
口腔科学 | 646篇 |
临床医学 | 346篇 |
内科学 | 968篇 |
皮肤病学 | 115篇 |
神经病学 | 291篇 |
特种医学 | 73篇 |
外科学 | 523篇 |
综合类 | 20篇 |
一般理论 | 1篇 |
预防医学 | 456篇 |
眼科学 | 51篇 |
药学 | 293篇 |
中国医学 | 49篇 |
肿瘤学 | 102篇 |
出版年
2023年 | 36篇 |
2022年 | 95篇 |
2021年 | 172篇 |
2020年 | 131篇 |
2019年 | 158篇 |
2018年 | 177篇 |
2017年 | 104篇 |
2016年 | 146篇 |
2015年 | 165篇 |
2014年 | 219篇 |
2013年 | 244篇 |
2012年 | 356篇 |
2011年 | 421篇 |
2010年 | 229篇 |
2009年 | 177篇 |
2008年 | 264篇 |
2007年 | 239篇 |
2006年 | 198篇 |
2005年 | 215篇 |
2004年 | 183篇 |
2003年 | 122篇 |
2002年 | 108篇 |
2001年 | 63篇 |
2000年 | 86篇 |
1999年 | 68篇 |
1998年 | 16篇 |
1997年 | 14篇 |
1996年 | 9篇 |
1995年 | 8篇 |
1994年 | 8篇 |
1993年 | 13篇 |
1992年 | 17篇 |
1991年 | 16篇 |
1990年 | 25篇 |
1989年 | 20篇 |
1988年 | 11篇 |
1987年 | 18篇 |
1986年 | 19篇 |
1985年 | 15篇 |
1984年 | 12篇 |
1983年 | 11篇 |
1982年 | 11篇 |
1981年 | 9篇 |
1979年 | 7篇 |
1974年 | 9篇 |
1972年 | 12篇 |
1970年 | 5篇 |
1968年 | 6篇 |
1967年 | 9篇 |
1965年 | 4篇 |
排序方式: 共有4711条查询结果,搜索用时 31 毫秒
1.
2.
Dalton Luiz Schiessel Ricardo K. Yamazaki Marcelo Kryczyk Isabela Coelho de Castro Adriana A. Yamaguchi Danielle C. T. Pequito 《Nutrition and cancer》2016,68(8):1369-1380
Objective: Polyunsaturated fatty acids n-3 (PUFA n-3) have shown effects in reducing tumor growth, in particular eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) abundantly present in fish oil (FO). When these fatty acids are provided in the diet, they alter the functions of the cells, particularly in tumor and immune cells. However, the effects of α-linolenic fatty acid (ALA), which is the precursor of EPA and DHA, are controversial. Thus, our objective was to test the effect of this parental fatty acid. Methods: Non-tumor-bearing and tumor-bearing Wistar rats (70 days) were supplemented with 1 g/kg body weight of FO or Oro Inca® (OI) oil (rich in ALA). Immune cells function, proliferation, cytokine production, and subpopulation profile were evaluated. Results: We have shown that innate immune cells enhanced phagocytosis capacity, and increased processing and elimination of antigens. Moreover, there was a decrease in production of pro-inflammatory cytokines (tumor necrosis factor-alpha (TNF-α) and interleukin 6 (IL-6)) by macrophages. Lymphocytes showed decreased proliferation capacity, increased cluster of differentiation 8 (CD8+) subpopulation, and increased TNF-α production. Conclusions: Oil rich in ALA caused similar immune modulation in cancer when compared with FO. 相似文献
3.
Iclea Rocha Gama Euclides Marinho Trindade-Filho Suzana Lima Oliveira Nassib Bezerra Bueno Isabelle Tenório Melo Cyro Rego Cabral-Junior Elenita M. Barros Jaqueline A. Galvão Wanessa S. Pereira Raphaela C. Ferreira Bruna R. Domingos Terezinha da Rocha Ataide 《Metabolic brain disease》2015,30(1):93-98
4.
5.
6.
7.
Otavio A C Clark Gary H Lyman Aldemar A Castro Luciana G O Clark Benjamin Djulbegovic 《Journal of clinical oncology》2005,23(18):4198-4214
PURPOSE: Current treatment for febrile neutropenia (FN) includes hospitalization for evaluation, empiric broad-spectrum antibiotics, and other supportive care. Clinical trials have reported conflicting results when studying whether the colony-stimulating factors (CSFs) improve outcomes in patients with FN. This Cochrane Collaboration review was undertaken to further evaluate the safety and efficacy of the CSFs in patients with FN. METHODS: An exhaustive literature search was undertaken including major electronic databases (CANCERLIT, EMBASE, LILACS, MEDLINE, SCI, and the Cochrane Controlled Trials Register). All randomized controlled trials that compare CSFs plus antibiotics versus antibiotics alone for the treatment of established FN in adults and children were sought. A meta-analysis of the selected studies was performed. RESULTS: More than 8,000 references were screened, with 13 studies meeting eligibility criteria for inclusion. The overall mortality was not influenced significantly by the use of CSF (odds ratio [OR] = 0.68; 95% CI, 0.43 to 1.08; P = .1). A marginally significant result was obtained for the use of CSF in reducing infection-related mortality (OR = 0.51; 95% CI, 0.26 to 1.00; P = .05). Patients treated with CSFs had a shorter length of hospitalization (hazard ratio [HR] = 0.63; 95% CI, 0.49 to 0.82; P = .0006) and a shorter time to neutrophil recovery (HR = 0.32; 95% CI, 0.23 to 0.46; P < .00001). CONCLUSION: The use of the CSFs in patients with established FN caused by cancer chemotherapy reduces the amount of time spent in hospital and the neutrophil recovery period. The possible influence of the CSFs on infection-related mortality requires further investigation. 相似文献
8.
9.